Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors (Q50977877)

26 March 2018

title

Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors (English)

1 reference

26 March 2018

1 reference

7

1 reference

26 March 2018

author name string

Pilar Mur

1

1 reference

26 March 2018

Manuela Mollejo

2

1 reference

26 March 2018

Yolanda Ruano

3

1 reference

26 March 2018

Ángel Rodríguez de Lope

4

1 reference

26 March 2018

Concepción Fiaño

5

1 reference

26 March 2018

Juan Fernando García

6

1 reference

26 March 2018

Aurelio Hernández-Laín

8

1 reference

26 March 2018

Juan A Rey

9

1 reference

26 March 2018

Bárbara Meléndez

10

1 reference

26 March 2018

publication date

21 May 2013

1 reference

26 March 2018

published in

Acta Neuropathologica

1 reference

26 March 2018

volume

126

1 reference

26 March 2018

issue

2

1 reference

26 March 2018

page(s)

277-289

1 reference

26 March 2018

Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas

cites work

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Analysis of the IDH1 codon 132 mutation in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Novel genomic alterations and mechanisms associated with tumor progression in oligodendroglioma and mixed oligoastrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

SMOC1 is a tenascin-C interacting protein over-expressed in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

CpG Island Methylation in Colorectal Cancer: Past, Present and Future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

IDH1 and IDH2 mutations in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Gene expression profiles associated with treatment response in oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Epigenomics of cancer - emerging new concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

IDH mutations in human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

IDH mutation impairs histone demethylation and results in a block to cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

KIAA0495/PDAM is frequently downregulated in oligodendroglial tumors and its knockdown by siRNA induces cisplatin resistance in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Genetic alterations associated with progression and recurrence in meningiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

p53 and autophagy in cancer: Guardian of the genome meets guardian of the proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p/19q loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

CpG island methylator phenotype (CIMP) in cancer: causes and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

DNMAD: web-based diagnosis and normalization for microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Polysomy of chromosomes 1 and/or 19 is common and associated with less favorable clinical outcome in oligodendrogliomas: fluorescent in situ hybridization analysis of 84 consecutive cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

CpG island hypermethylation in human astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00401-013-1130-9

10.1007/S00401-013-1130-9

21 January 2018

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018